Avoidable Mortality Across US States and High-Income Countries

被引:0
|
作者
Papanicolas, Irene [1 ]
Niksch, Maecey [1 ]
Figueroa, Jose F. [2 ,3 ]
机构
[1] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA
[3] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Boston, MA USA
关键词
HEALTH-CARE; AMENABLE MORTALITY; UNITED-STATES; POLICY; FUTURE;
D O I
10.1001/jamainternmed.2025.0155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ImportanceAlthough there are increasing differences in health policy and population health across US states over the past decade, little is known about how US states compare with other countries on avoidable mortality. ObjectiveTo compare trends in avoidable mortality across US states and countries in the European Union (EU) and the Organisation for Economic Co-operation and Development (OECD). Design, Setting, and ParticipantsRetrospective, population-based, repeated cross-sectional study comparing changes in avoidable mortality among decedents aged 0 to 74 years in 50 US states (and Washington, DC) and 40 high-income countries between 2009 and 2021. Data analysis was conducted from May to July 2024. Main Outcomes and MeasuresAvoidable mortality comprising both preventable deaths related to prevention and public health and treatable deaths related to timely and effective health care treatment. ResultsBetween 2009 and 2019, total avoidable mortality increased in all US states (median [IQR], 29.0 [20.1 to 44.2] deaths per 100 000 people), while it decreased in most comparator countries (-14.4 [-28.4 to -8.0]). During this period, variation in avoidable mortality widened across US states (2009: median [IQR], 251.1 [228.4 to 280.4]; 2019: 282.8 [249.1 to 329.5]), but narrowed in comparator countries (2009: 201.5 [166.2 to 320.8]; 2019: 187.1 [152.0 to 298.2]). During the COVID-19 pandemic (2019-2021), avoidable mortality increased for all US states (median [IQR], 101.5 [64.7 to 143.1]) and comparator countries (25.8 [9.1 to 117.7]). The states and countries that experienced the greatest increase in avoidable deaths during the COVID-19 period were those with the highest baseline avoidable mortality (Pearson rho = 0.86; P < .001). Health spending and avoidable mortality have a consistent, negative, and significant association among comparator countries (2019: Pearson rho = -0.7; P < .001) but no statistically significant association within US states (2019: Pearson rho = -0.12; P = .41). Conclusions and RelevanceThis cross-sectional study found that the stark contrast in avoidable mortality trends between all US states compared with EU and OECD countries suggests that broad, systemic factors play a role in worsening US population health. While other countries appear to make gains in health with increases in health care spending, such an association does not exist across US states, raising questions regarding US health spending efficiency.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Inequalities in life expectancy and cardiometabolic disease mortality across and within high-income countries
    Ho, Jessica Y.
    Hendi, Arun S.
    CELL METABOLISM, 2024, 36 (02) : 224 - 228
  • [2] US neonatal mortality rates are likely lower than many high-income countries
    Grunebaum, Amos
    Benn, Kiesha
    Chervenak, Frank A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S108 - S108
  • [3] Is Austerity Responsible for the Stalled Mortality Trends Across Many High-Income Countries? A Systematic Review
    Broadbent, Philip
    Walsh, David
    Katikireddi, Srinivasa Vittal
    Gallagher, Christine
    Dundas, Ruth
    McCartney, Gerry
    INTERNATIONAL JOURNAL OF SOCIAL DETERMINANTS OF HEALTH AND HEALTH SERVICES, 2024, 54 (04) : 362 - 379
  • [4] Consequences of US FDA approval decisions in high-income countries
    Jenei, Kristina
    LANCET ONCOLOGY, 2022, 23 (04): : E160 - E160
  • [5] The mortality rates for tuberculosis remain high even in high-income countries
    Kwon, Y-S.
    Koh, W-J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (03) : 275 - 276
  • [6] Progress Stalled? The Uncertain Future of Mortality in High-Income Countries
    Dowd, Jennifer Beam
    Polizzi, Antonino
    Tilstra, Andrea M.
    POPULATION AND DEVELOPMENT REVIEW, 2024,
  • [7] Stillbirth in high-income countries
    Dorling, Jon
    Springett, Anna
    Amaral, Catarina
    Golightly, Shona
    Stephens, Imogen
    LANCET, 2011, 378 (9794): : 874 - 875
  • [8] Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries
    Chow, Ryan D.
    Bradley, Elizabeth H.
    Gross, Cary P.
    JAMA HEALTH FORUM, 2022, 3 (05): : E221229
  • [9] A comparison of social prescribing approaches across twelve high-income countries*
    Scarpetti, Giada
    Shadowen, Hannah
    Williams, Gemma A.
    Winkelmann, Juliane
    Kroneman, Madelon
    Groenewegen, Peter P.
    De Jong, Judith D.
    Fronteira, Ines
    Augusto, Goncalo Figueiredo
    Hsiung, Sonia
    Slade, Sian
    Rojatz, Daniela
    Kallayova, Daniela
    Katreniakova, Zuzana
    Nagyova, Iveta
    Kylanen, Marika
    Vracko, Pia
    Jesurasa, Amrita
    Wallace, Zoe
    Wallace, Carolyn
    Costongs, Caroline
    Barnes, Andrew J.
    van Ginneken, Ewout
    HEALTH POLICY, 2024, 142
  • [10] DISPARITIES IN MYOCARDIAL INFARCTION BY SEX ACROSS 6 HIGH-INCOME COUNTRIES
    Lu, Hannah
    Cram, Peter
    Landon, Bruce E.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S268 - S268